Pfizer share price zooms over 19% to new 52-week high on COVID-19 vaccine news; rallies 63% since March

Pfizer share price zooms over 19% to new 52-week high on COVID-19 vaccine news; rallies 63% since March

Pfizer also indicated that the company is on track later this month to file an emergency use application with US regulators.
Check the source here –Source, Financial Express.

Leave your comment
Comment
Name
Email
Change Language